What is the MacViewer ? (formerly MacScope)
A patented* method and device that enables
early detection of irregularities in the macula
and surrounding retinal region. This is often the
result of the onset of Age-related Macular
Degeneration (AMD), but may also be caused by
other diseases and conditions, such as Diabetic
Why is this important?
- AMD is the leading cause of blindness,
occurring predominantly in those over age 55
- While investigative drugs and procedures are
showing promise, there is currently no cure
- Studies have shown that early detection can
lead to a better chance for reversal or at least
slowing the advance
- Advanced cases require surgery, which is not
always successful in restoring vision
here for more information from the NIH on
Diabetic Retinopathy and other eye conditions.
How does it work?
The MacViewer generates a specific and user-controllable color and light
pattern which enables the patient to observe any
irregularities that may be present in the macular
region. Once the irregularities have been identified they can be
documented and communicated or transmitted
to a healthcare professional for review as
What are its advantages?
The MacViewer helps identify irregularities in the central
visual field quickly, simply, and at an early stage of development,
while the condition may still be readily treated
with some of the new and emerging therapeutic methods. The
device may also provide the ability to observe
the effects of the therapeutic regimen, and
therefore self-monitor progress and improvement.
When will it be available?
Pre-clinical tests with the method and device
demonstrated positive results. A multi-center trial
is underway and pending the results
and regulatory approvals, the product will be offered commercially.
If you represent a potential site for clinical study
of the MacViewer, please contact us to discuss
participation in this phase.
Sensory Arts & Science is working to
commercialize this important innovation, and is
interested in working with companies who have
complementary products for treating Macular
Degeneration and other conditions of the central visual field.
Click here to request
more information about the MacViewer.
* U.S. Patent 7,166,079; additional patents pending